Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2011

Bao Bo-Ying, Pao Jiunn-Bey, Huang Chun-Nung, Pu Yeong-Shiau, Chang Ta-Yuan, Lan Yu-Hsuan, Lu Te-Ling, Lee Hong-Zin, Juang Shin-Hun, Chen Lu-Min, Hsieh Chi-Jeng, Huang Shu-Pin

Abstract excerpt

PURPOSE: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), are involved in cancer initiation and progression. We hypothesized that genetic variations in miRNAs and miRNA target sites could be associated with the efficacy of androgen-deprivation therapy (ADT) in men with prostate cancer. EXPERIMENTAL DESIGN: We systematically evaluated 61 common single nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Gonadotropin-Releasing Hormone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to MicroRNAs

Share to Orchiectomy

Share to Prostatic Neoplasms

Share to RNA Interference

Share to Treatment Outcome

Source

Identifiers

PMID: 21149617
DOI: 10.1158/1078-0432.CCR-10-2648

Genes

SYT9
CDON
GABRA1
IFI30
PALLD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy.PMID 21149617Read ↗

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.Semantic proximity Read ↗

Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and in Silico CharacterizationSemantic proximity Read ↗

Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.Semantic proximity Read ↗

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.Semantic proximity Read ↗

How Cancer Risk SNPs May Contribute to Prostate Cancer Disparities.Semantic proximity Read ↗

A N7-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate CancerSemantic proximity Read ↗

Mapping genetic variability in mature miRNAs and miRNA binding sites in prostate cancer.Semantic proximity Read ↗

Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review.Semantic proximity Read ↗

miRSNP-Based Approach Identifies a miRNA That Regulates Prostate-Specific Antigen in an Allele-Specific Manner.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.